Ado-trastuzumab emtansine and Jivi Intravenous
Determining the interaction of Ado-trastuzumab emtansine and Jivi Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: antihemophilic factor
Brand name: Jivi, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Obizur
Synonyms: Jivi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Jolessa
- Ado-trastuzumab emtansine-Jolessa extended-cycle
- Ado-trastuzumab emtansine-Jolivette
- Ado-trastuzumab emtansine-Jornay PM
- Ado-trastuzumab emtansine-Juleber
- Ado-trastuzumab emtansine-Juluca
- Jivi Intravenous-Ado-trastuzumab emtansine Intravenous
- Jivi Intravenous-Adox Pak 2/100
- Jivi Intravenous-Adoxa
- Jivi Intravenous-Adoxa CK
- Jivi Intravenous-Adoxa Pak
- Jivi Intravenous-Adoxa Pak 1/100